BACKGROUND: Dysentery accounts for 20% of the 4.6 million diarrhea-associated deaths among children in developing countries, with the risk from death in dysenteric persistent diarrhea 10-fold higher than that in acute dysentery. Although Shigella accounts for the majority of dysenteric episodes, very little is known about the epidemiology of postshigellosis persistent diarrhea. METHODS: Rural Bangladeshi children younger than 5 years of age (n = 1,756) were followed for 1 month after exposure to sentinel cases of Shigella dysentery. The likelihood of an acute diarrheal episode becoming persistent was assessed. RESULTS: Diarrhea caused by Shigella was significantly associated with an increased risk of persistent diarrhea (age-adjusted relative risk, 1.83; 95% confidence interval, 1.19 to 2.81). Despite the use of nalidixic acid in dysenteric episodes, persistent diarrhea occurred in 23% of children with shigellosis. Infection by multiply antibiotic-resistant Shigella isolates (age-adjusted relative risk, 3.76; 95% confidence interval, 1.51 to 9.36) and occurrence of shigellosis during infancy were observed to be risk factors for initiation of Shigella diarrhea persistence. However, 88% of the persistent shigellosis episodes occurred in older children, 50% were associated with nondysenteric shigellosis and 79% were caused by Shigella species other than Shigella dysenteriae 1. CONCLUSIONS: These data demonstrate the importance of Shigella as a cause of persistent diarrhea and indicate that strategies to prevent postshigellosis persistent diarrhea must be broad-based, with a focus on older children as well as infants, management of nondysenteric as well as dysenteric disease and prevention of diarrhea caused by multiple Shigella species.
BACKGROUND: Dysentery accounts for 20% of the 4.6 million diarrhea-associated deaths among children in developing countries, with the risk from death in dysenteric persistent diarrhea 10-fold higher than that in acute dysentery. Although Shigella accounts for the majority of dysenteric episodes, very little is known about the epidemiology of postshigellosis persistent diarrhea. METHODS: Rural Bangladeshi children younger than 5 years of age (n = 1,756) were followed for 1 month after exposure to sentinel cases of Shigella dysentery. The likelihood of an acute diarrheal episode becoming persistent was assessed. RESULTS:Diarrhea caused by Shigella was significantly associated with an increased risk of persistent diarrhea (age-adjusted relative risk, 1.83; 95% confidence interval, 1.19 to 2.81). Despite the use of nalidixic acid in dysenteric episodes, persistent diarrhea occurred in 23% of children with shigellosis. Infection by multiply antibiotic-resistant Shigella isolates (age-adjusted relative risk, 3.76; 95% confidence interval, 1.51 to 9.36) and occurrence of shigellosis during infancy were observed to be risk factors for initiation of Shigella diarrhea persistence. However, 88% of the persistent shigellosis episodes occurred in older children, 50% were associated with nondysenteric shigellosis and 79% were caused by Shigella species other than Shigella dysenteriae 1. CONCLUSIONS: These data demonstrate the importance of Shigella as a cause of persistent diarrhea and indicate that strategies to prevent postshigellosis persistent diarrhea must be broad-based, with a focus on older children as well as infants, management of nondysenteric as well as dysenteric disease and prevention of diarrhea caused by multiple Shigella species.
Authors: P B Pavlinac; D M Denno; G C John-Stewart; F M Onchiri; J M Naulikha; E A Odundo; C E Hulseberg; B O Singa; L E Manhart; J L Walson Journal: J Pediatric Infect Dis Soc Date: 2015-07-12 Impact factor: 3.164
Authors: Karen L Kotloff; William C Blackwelder; Dilruba Nasrin; James P Nataro; Tamer H Farag; Annemieke van Eijk; Richard A Adegbola; Pedro L Alonso; Robert F Breiman; Abu Syed Golam Faruque; Debasish Saha; Samba O Sow; Dipika Sur; Anita K M Zaidi; Kousick Biswas; Sandra Panchalingam; John D Clemens; Dani Cohen; Roger I Glass; Eric D Mintz; Halvor Sommerfelt; Myron M Levine Journal: Clin Infect Dis Date: 2012-12 Impact factor: 9.079
Authors: Adi Behar; Kate Susan Baker; Ravit Bassal; Analia Ezernitchi; Lea Valinsky; Nicholas R Thomson; Daniel Cohen Journal: Emerg Infect Dis Date: 2018-07 Impact factor: 6.883
Authors: Karoun H Bagamian; Chloe Puett; John D Anderson; Farzana Muhib; Clint Pecenka; Jere Behrman; Robert F Breiman; Ijeoma Edoka; Susan Horton; Gagandeep Kang; Karen L Kotloff; Claudio F Lanata; James A Platts-Mills; Firdausi Qadri; Elizabeth T Rogawski McQuade; Christopher Sudfeld; Pascale Vonaesch; Thomas F Wierzba; Suzanne Scheele Journal: Vaccine X Date: 2022-09-21
Authors: D Cohen; R Bassal; S Goren; T Rouach; D Taran; B Schemberg; N Peled; Y Keness; S Ken-Dror; V Vasilev; I Nissan; V Agmon; T Shohat Journal: Epidemiol Infect Date: 2014-02-20 Impact factor: 4.434
Authors: Paul F Horwood; Kevin W Soli; Tobias Maure; Yuichi I Naito; Ayako Morita; Kazumi Natsuhara; Kiyoshi Tadokoro; Jun Baba; Shingo Odani; Eriko Tomitsuka; Katsura Igai; Jo-Ann Larkins; Peter M Siba; William Pomat; Emma S McBryde; Masahiro Umezaki; Andrew R Greenhill Journal: Am J Trop Med Hyg Date: 2017-09-21 Impact factor: 2.345